In United States v. Skrmetti, the Supreme Court ruled that Tennessee’s ban on gender-affirming care for minors was not unconstitutional—the first case of its kind on which the court has ruled.
An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could eventually be an alternative or add-on to popular GLP-1 medications.
Robert Malone, a mainstay in conspiratorial circles, and Martin Kulldorff, a coauthor of the widely criticized Great Barrington Declaration, are two of the most concerning picks.
So-called “less-lethal” weapons like those that have been used against demonstrators in Los Angeles can cause severe, lasting harm like nerve or brain damage or blindness. They can also kill.
Outro, which is now available in seven states, wants to help people taper off antidepressants without experiencing debilitating side effects.
La variante de covid NB.1.8.1 presenta mutaciones específicas que podrían aumentar su capacidad de transmisión y disminuir parcialmente la eficacia neutralizante de ciertos anticuerpos.
A study claimed that people who eat high-fat, low-carb diets weren’t seeing their arteries fill up with plaque, despite having high levels of blood cholesterol. Critics disagreed—and all hell broke loose.
Curious about mushroom supplements? Here's what they do, what the science says, and how to know if they're right for you—according to the experts.
Researchers are trying to understand more about the biological and social differences that contribute to later diabetes diagnoses and worse outcomes in women.
As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 medication injected daily instead of weekly.
